In a prospective study, prediabetes was an independent risk factor for hyperfiltration and increased albuminuria.
A phosphodiesterone 5 inhibitor may improve metabolic parameters that predispose people to developing diabetes.
Researchers noted a decrease in plasminogen activator inhibitor-1 without affecting tissue-plasminogen activator.
Early intervention is essential to treating neuropathy in those with prediabetes.
Sleep apnea treatment may improve glucose control and blood pressure and prevent progression to diabetes in patients with prediabetes.
The ADA’s 2015 Standards for Diabetes Care focus on ethnic differences in risk, blood pressure targets and treatment goals.
Diabetes or depression may increase the risk for progressing from mild cognitive impairment to dementia.